AR098788A1 - Piperidinil-tetrahidroquinolinas sustituidas - Google Patents
Piperidinil-tetrahidroquinolinas sustituidasInfo
- Publication number
- AR098788A1 AR098788A1 ARP140104708A ARP140104708A AR098788A1 AR 098788 A1 AR098788 A1 AR 098788A1 AR P140104708 A ARP140104708 A AR P140104708A AR P140104708 A ARP140104708 A AR P140104708A AR 098788 A1 AR098788 A1 AR 098788A1
- Authority
- AR
- Argentina
- Prior art keywords
- heterocycle
- alkyl
- substituents
- diabetic
- solvates
- Prior art date
Links
- 125000001424 substituent group Chemical group 0.000 abstract 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- 239000012453 solvate Substances 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 230000002093 peripheral effect Effects 0.000 abstract 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- 230000006806 disease prevention Effects 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- STWMVDMOJPLMPX-UHFFFAOYSA-N 1-piperidin-1-yl-3,4-dihydro-2h-quinoline Chemical class C1CCCCN1N1C2=CC=CC=C2CCC1 STWMVDMOJPLMPX-UHFFFAOYSA-N 0.000 abstract 1
- 206010061666 Autonomic neuropathy Diseases 0.000 abstract 1
- 201000002829 CREST Syndrome Diseases 0.000 abstract 1
- 208000008960 Diabetic foot Diseases 0.000 abstract 1
- 206010056340 Diabetic ulcer Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010022562 Intermittent claudication Diseases 0.000 abstract 1
- 208000012322 Raynaud phenomenon Diseases 0.000 abstract 1
- 208000001435 Thromboembolism Diseases 0.000 abstract 1
- JKZCEMTXGWARPE-UHFFFAOYSA-N [C].N1CCC1 Chemical group [C].N1CCC1 JKZCEMTXGWARPE-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 201000009101 diabetic angiopathy Diseases 0.000 abstract 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 1
- -1 hydroxy , monofluoromethyl Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 208000021156 intermittent vascular claudication Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 abstract 1
- 208000027232 peripheral nervous system disease Diseases 0.000 abstract 1
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13198385 | 2013-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR098788A1 true AR098788A1 (es) | 2016-06-15 |
Family
ID=49876400
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140104708A AR098788A1 (es) | 2013-12-19 | 2014-12-17 | Piperidinil-tetrahidroquinolinas sustituidas |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR098788A1 (fr) |
| MA (1) | MA39122B1 (fr) |
-
2014
- 2014-12-16 MA MA39122A patent/MA39122B1/fr unknown
- 2014-12-17 AR ARP140104708A patent/AR098788A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MA39122A1 (fr) | 2017-11-30 |
| MA39122B1 (fr) | 2018-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123391T1 (el) | (2s)-n-[(1s)-1-kyano-2-φainyλaιθyλ]-1,4-oξazeπan-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης ι | |
| JOP20130256B1 (ar) | مركبات سلفامويل اريل اميدات واستعمالها كمواد علاجية لمعالجة التهاب الكبد نوع بي | |
| MX2020003415A (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso. | |
| EA201591727A1 (ru) | Соединения биариламида в качестве ингибиторов киназы | |
| UY36371A (es) | Compuestos de indolcarboxamida inhibidores de quinasas tipo btk y tipo tec | |
| AR090241A1 (es) | INHIBIDORES DE LA b-SECRETASA | |
| SV2016005234A (es) | Análogos de cortistatina y síntesis y usos de los mismos | |
| EA201690687A1 (ru) | Ингибиторы репликации вируса иммунодефицита | |
| MX2017004129A (es) | Derivado de acido 4-(4-(4-fenilureido-naftalen-1-il)oxi-piridin-2- il)amino-benzoico como inhibidor de quinasa p38. | |
| EA201591890A1 (ru) | Производные n-фенилкарбоксамида и их применение в качестве лекарственных препаратов для лечения гепатита b | |
| AR087668A1 (es) | Derivados de oxazina y su uso en el tratamiento de enfermedades | |
| EA201490300A1 (ru) | 4-имидазопиридазин-1-ил-бензамиды и 4-имидазотриазин-1-ил-бензамиды в качестве btk-ингибиторов | |
| AR090994A1 (es) | Uracilos sustituidos biciclicamente y uso de los mismos | |
| GEP20207095B (en) | Fused bicyclic heteroaryl derivatives having activity as phd inhibitors | |
| AR089781A1 (es) | Fluorometil-5,6-dihidro-4h-[1,3]oxazinas | |
| UY35887A (es) | Piperidinil-tetrahidroquinolinas sustituidas | |
| BR112015018491A2 (pt) | triterpenoides c-19-modificados com atividade inibidora de maturação de hiv | |
| BR112014003071A2 (pt) | tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical | |
| CU20160089A7 (es) | PIPERIDINILTETRAHIDROQUINOLINAS SUSTITUIDAS COMO RECEPTORES ADRENÉRGICOS a2C | |
| BR112015015250A2 (pt) | derivados de pirrolidina, composições farmacêuticas e usos dos mesmos | |
| UY28787A1 (es) | Derivados de beta-aminoacidos como inhibidores del factor xa | |
| CL2013000021A1 (es) | Forma cristalina delta de la sal de arginina de perindoprilo; procedimiento de preparacion; composiciones farmaceuticas que la contienen; y su uso par el tratamiento de las enfermedades cardiovasculares, tales como hipertension arterial, insuficiencia cardiaca o enfermedad coronaria estable. | |
| PH12015502203A1 (en) | Phenyl derivative | |
| MX375545B (es) | Derivados de piridazinona como inhibidores de las fosfoinositido-3-cinasas. | |
| AR101364A1 (es) | Derivado de ácido azolcarboxílico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |